Search results for "pemphigus"

showing 9 items of 29 documents

Epidemiology of desquamative gingivitis: evaluation of 125 patients and review of the literature

2009

Background  Desquamative gingivitis (DG) is a descriptive term used to indicate epithelial desquamation, erythema, erosions, and/or vesiculobullous lesions of the gingiva. DG is commonly associated with several mucocutaneous disorders and systemic conditions that may carry a poor prognosis and high morbidity; however, there are no clear data concerning the frequency of these disease associations. Methods  We investigated the epidemiologic features of DG in 125 patients and compared our findings with information from a literature review. Results  In our series, 88% of patients with DG had one of the following three disorders: oral lichen planus (OLP), mucous membrane pemphigoid (MMP), or pem…

AdultMalePathologymedicine.medical_specialtyErythemaAdolescentMucocutaneous zoneDermatologyGingivitisYoung AdultSettore MED/28 - Malattie OdontostomatologicheEpidemiologymedicineHumansSex organepidemiology desquamative gingivitisAgedAged 80 and overbusiness.industryPemphigus vulgarisMiddle Agedmedicine.diseaseDermatologyGingivitisDesquamative gingivitisstomatognathic diseasesOral lichen planusFemalemedicine.symptombusiness
researchProduct

Cleavage of desmoglein 3 can explain its depletion from keratinocytes in pemphigus vulgaris.

2008

We have previously demonstrated that serum of patients with pemphigus vulgaris induces reduction of desmoglein 3 (Dsg3) half-life in keratinocytes (FEBS Lett 2006: 580: 3276). This phenomenon seems to occur as a consequence of the progressive depletion of Dsg3 from desmosomes. Here we reported that reduction of full-length Dsg3 may be due to its progressive cleavage, leading to the formation of two fragmentation products with apparent molecular masses of about 60 kDa (fragment 1) and 70 kDa (fragment 2), as revealed by Western blotting. Unexpectedly, analysis of fragmentation pattern suggested cleavage to occur intracellularly. Consistently, fragment 1 was shed and localized within the cyto…

KeratinocytesPathologymedicine.medical_specialtyBlotting WesternPlakoglobinDermatologyBiologyCleavage (embryo)BiochemistryCell LinemedicineHumanseducationMolecular Biologyeducation.field_of_studyDesmoglein 3Desmoglein 1Pemphigus vulgarisBlood Proteinsmedicine.diseaseMolecular biologyBlotPemphigusmedicine.anatomical_structureDesmoplakinsDesmoglein 1Desmoglein 3gamma CateninKeratinocytePemphigusExperimental dermatology
researchProduct

CEFACLOR INDUCED PEMPHIGUS VULGARIS

2004

Pemphigus is a chronic disease with an outcome that is not without risk. It is characterised by loss of the intraepithelial cell-cell relationship (acantholysis). Underlying the disease is an autoimmune disorder in which the desmosomes are damaged by antibodies directed against particular molecules called desmogleins (particularly 3 and 1). Various types of pemphigus have been described with different antibody profiles and clinical signs. In the present paper, a case of pemphigus vulgaris associated with the medication cefaclor monohydrate is reported. Histological and immunological evaluation of the biopsy sample led to a diagnosis of pemphigus vulgaris. The patient, who was not hospitalis…

cefaclor pemphigus vulgaris
researchProduct

Pharmacokinetic evaluation of mycophenolate mofetil for pemphigus.

2011

Introduction: Pemphigus is an autoimmune blistering disease of the skin and mucous membranes characterized by the development of autoantibodies against the desmosomal proteins, desmoglein-1 and -3. Before the advent of corticosteroids, therapy was almost fatal. The introduction of high-dose corticosteroid therapy has reduced mortality rates to similar to 10%, but long-term use of steroids can lead to side effects, many of which are severe and associated with significant morbidity. Thus, the major goal of pemphigus therapy has been to reduce the patient's cumulative exposure to systemic corticosteroids. Over the last 2 decades, a range of corticosteroid-sparing immunosuppressive agents have …

medicine.medical_specialtyToxicologyMycophenolateMycophenolic acidPharmacokineticsAdrenal Cortex HormonesmedicineInitial treatmentimmunosuppressant inosine monophosphate dehydrogenase mycophenolate mofetil mycophenolic acid pemphigus pharmacokinetic treatmentHumansPharmacologyintegumentary systembusiness.industryMortality rateAutoantibodyGeneral MedicineMycophenolic Acidmedicine.diseaseDermatologyPemphigusImmunologybusinessImmunosuppressive AgentsPemphigusmedicine.drugBlistering diseaseExpert opinion on drug metabolismtoxicology
researchProduct

COVID‐19 and exacerbation of dermatological diseases: A review of the available literature

2021

Abstract Since the emergence of the new coronavirus disease 19 (COVID‐19) pandemic, there has been a concern for the patients with chronic autoimmune diseases including dermatological conditions over the potential exacerbation of these underlying conditions after infection with severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV2). We performed a systematic review to evaluate presentations, postinfection change in the manifestation, diagnosis, and management of flare‐ups of underlying dermatologic disease in patients with COVID‐19. A total of 17 articles were recovered reporting on flare‐ups of dermatological disease including pemphigus vulgaris, psoriasis, subacute cutaneous lupus er…

medicine.medical_specialtyExacerbationShort ReportDiseaseSclerodermaSubacute cutaneous lupus erythematosusexacerbationShort ReportsCOVID‐19PsoriasismedicineHumansflare‐upworseningskin and connective tissue diseasesPandemicsSARS‐Cov2business.industrySARS-CoV-2Pemphigus vulgarispemphigusCOVID-19General MedicinepsoriasisAlopecia areatamedicine.diseaseDermatologydermatologyPemphigusRNA ViralbusinessDermatologic Therapy
researchProduct

Mycophenolate mofetil and enteric-coated mycophenolate sodium in the treatment of pemphigus vulgaris and pemphigus foliaceus.

2014

What is known and objective: Pemphigus is a severe, potentially life-threatening autoimmune blistering disease. The use of corticosteroids has dramatically improved the prognosis and changed its course. However, current morbidity of pemphigus is largely iatrogenic, caused by side effects of the long-term, high-dose corticosteroid therapy that is necessary to sustain disease control. In order to minimize side effects, a range of corticosteroid-sparing immunosuppressive agents have been introduced, including mycophenolate mofetil (MMF) and enteric-coated mycophenolate sodium (EC-MPS). A systematic review was performed to evaluate the effectiveness of MMF and EC-MPS in the treatment of pemphig…

medicine.medical_specialtyEnteric-coated mycophenolate sodium mycophenolate mofetil mycophenolic acid pemphigus foliaceus pemphigus vulgaris therapyDermatologyMycophenolateMycophenolic acidimmune system diseasesmedicineSettore MED/35 - Malattie Cutanee E VenereeHumansEnteric coatedskin and connective tissue diseasesGlucocorticoidsPemphigus foliaceusintegumentary systembusiness.industryPemphigus vulgarisMycophenolate SodiumMycophenolic AcidPrognosismedicine.diseaseDermatologyPemphigusTreatment OutcomeDrug Therapy CombinationDermatologic AgentsbusinessImmunosuppressive AgentsPemphigusmedicine.drugBlistering disease
researchProduct

Fallberichte

2004

High-dose immunoglobulins (IVIG) are important agents in the treatment of numerous autoimmune disorders. In the field of dermatology, increasing numbers of patients with bullous autoimmune disorders and mixed connective tissue diseases have been treated. We successfully treated a patient with pemphigus vulgaris with IVIG, after he had developed osteonecrosis of his right femoral head while on azathioprine and corticosteroids. After reduction of oral corticosteroids, his disease flared dramatically. The addition of a high dose immunosuppressive regimen including azathioprine and dapsone failed to help. Thus high dose IVIG (2 mg/kg, 4 weeks interval) therapy was initiated and induced complete…

education.field_of_studymedicine.medical_specialtyintegumentary systembusiness.industryPemphigus vulgarisAutoantibodyConnective tissueAzathioprineDermatologyDapsonemedicine.diseaseDermatologyFemoral headmedicine.anatomical_structureDesmoglein 1Desmoglein 3medicineeducationbusinessmedicine.drugJournal der Deutschen Dermatologischen Gesellschaft
researchProduct

Immune-Mediated Desquamative Gingivitis and Optical Coherence Tomography Diagnostic Patterns: Clinical Implication from a Systematic Review

2021

Desquamative Gingivitis (DG) comprises heterogeneous clinical manifestations of numerous immune-mediated muco-cutaneous diseases. Optical Coherence Tomography (OCT) has been proposed as a valuable diagnostic support even if, to date, there are no standardized OCT-diagnostic patterns applicable to DGs. A systematic review was performed to detect existing data on in vivo OCT diagnostic patterns of the most common immune-mediated DGs (i.e., pemphigus vulgaris, mucous membrane pemphigoid and oral lichen planus). It has been found that OCT exhibits specific patterns that address the diagnosis of DG by pemphigus vulgaris (i.e., intraepithelial unilocular blister, reduced epithelial thickness, pre…

Medicine (General)medicine.medical_specialtyClinical Biochemistryoral mucous membrane pemphigoidR5-920Immune systemOptical coherence tomographyMedicineskin and connective tissue diseasesPathologicaloptical coherence tomographyintegumentary systemmedicine.diagnostic_testbusiness.industryBrief Reportoral pemphigus vulgarisPemphigus vulgarisOral pemphigus vulgarismedicine.diseaseDermatologydesquamative gingivitiseye diseasesDesquamative gingivitisstomatognathic diseasesMucous membrane pemphigoidDesquamative gingivitis Optical coherence tomography Oral mucous membrane pemphigoid Oral pemphigus vulgarisOral lichen planusbusinessDiagnostics
researchProduct

Evaluation of desmoglein 1 and 3 autoantibodies in pemphigus vulgaris: correlation with disease severity

2020

Background Pemphigus is an autoimmune blistering disease of the skin and mucous membranes caused by autoantibodies against desmoglein 1 (Dsg1) and desmoglein 3 (Dsg3). Pemphigus vulgaris (PV) is the most common form of pemphigus. The aim of this study was to assess the correlation between the levels of anti-desmoglein 1 and 3 autoantibodies and the severity of PV disease. Material and Methods Nineteen newly diagnosed patients with pemphigus vulgaris were enrolled in this study. The titers of Dsg in subjects by using enzyme-linked immunosorbent assay (ELISA) were done at diagnosis time-point, 4th and 8th weeks after the initiation of treatment, and the correlation of antibodies with the oral…

education.field_of_studyOral Medicine and Pathologyintegumentary systembusiness.industryResearchMucocutaneous zonePemphigus vulgarisAutoantibodymedicine.disease:CIENCIAS MÉDICAS [UNESCO]Desmoglein030207 dermatology & venereal diseases03 medical and health sciencesPemphigusTiter0302 clinical medicineDesmoglein 1030220 oncology & carcinogenesisUNESCO::CIENCIAS MÉDICASImmunologyDesmoglein 3medicinebusinesseducationGeneral DentistryJournal of Clinical and Experimental Dentistry
researchProduct